Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/22/2023 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 12.1k | $25.74 | $310.3k | | 05/22/2023 |
05/22/2023 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 6k | $0.00 | $0 | | 05/22/2023 |
05/23/2022 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 12.8k | $24.14 | $309.2k | | 05/23/2022 |
05/23/2022 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 6.4k | $0.00 | $0 | | 05/23/2022 |
05/21/2021 | Vir Biotechnology, Inc. | VIR | Grant | Common Stock | 3.4k | $0.00 | $0 | | 05/21/2021 |
05/21/2021 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 6.7k | $45.28 | $305.5k | | 05/21/2021 |
02/04/2021 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Director Stock Option (Right to Buy) | 25k | $20.50 | $512.5k | | 02/04/2021 |
12/09/2020 | Vir Biotechnology, Inc. | VIR | Grant | Stock Option (Right to Buy) | 46.5k | $29.43 | $1.4M | | 12/09/2020 |
05/21/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Stock Option (right to buy) | 24k | $0.63 | $15k | | 05/21/2020 |
05/06/2020 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 1.4k | $3.65 | $5.2k | | 05/06/2020 |
06/19/2019 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Stock Option (right to buy) | 12k | $2.36 | $28.3k | | 06/19/2019 |
05/08/2019 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 20k | $0.58 | $11.7k | | 05/08/2019 |
01/22/2019 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 525k | $4.63 | $2.4M | | 01/22/2019 |
06/27/2018 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Stock Option (right to buy) | 12k | $6.46 | $77.5k | | 06/27/2018 |
05/15/2018 | aTYR PHARMA INC | LIFE | Grant | Stock Option (right to buy) | 20k | $1.35 | $27k | | 05/15/2018 |
02/22/2018 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 275k | $7.77 | $2.1M | | 02/22/2018 |
01/19/2018 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Grant | Stock Option (right to buy) | 12.5k | $0.69 | $8.6k | | 01/19/2018 |
12/29/2017 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 1.1M | $3.40 | $3.7M | | 12/29/2017 |
11/01/2016 | INVIVO THERAPEUTICS HOLDINGS CORP. | NVIV | Grant | Stock Option (right to buy) | 25k | $4.25 | $106.2k | | 11/01/2016 |